期刊文献+

大剂量奥曲肽分别联合兰索拉唑、奥美拉唑治疗肝硬化并上消化道出血的效果比较 被引量:11

Comparison of the effects of high-dose octreotide combined with lansoprazole and omeprazole in the treatment of cirrhosis with upper gastrointestinal bleeding
下载PDF
导出
摘要 目的比较大剂量奥曲肽分别联合兰索拉唑、奥美拉唑治疗肝硬化并上消化道出血的效果。方法回顾性分析我院收治的157例肝硬化并上消化道出血患者的临床资料,其中采用大剂量奥曲肽联合兰索拉唑治疗者79例,设为A组;采用大剂量奥曲肽联合奥美拉唑治疗者78例,设为B组。比较两组的治疗效果。结果治疗后3 d,两组的胃液pH及血红蛋白水平均升高,且A组高于B组(P<0.05)。A组的止血时间短于B组(P<0.05)。A组的治疗总有效率高于B组(P<0.05)。结论大剂量奥曲肽联合兰索拉唑治疗肝硬化并上消化道出血,更利于改善患者的胃液pH和血红蛋白水平,缩短出血时间,提高治疗效果。 Objective To compare the effects of high-dose octreotide combined with lansoprazole and omeprazole in the treatment of cirrhosis with upper gastrointestinal bleeding.Methods The clinical data of 157 cirrhosis patients with upper gastrointestinal bleeding admitted in our hospital were analyzed retrospectively.Among them,79 cases were treated with high-dose octreotide combined with lansoprazole,which was set as group A;78 cases were treated with high-dose octreotide combined with omeprazole,which was set as group B.The therapeutic effects of the two groups were compared.Results Three days after treatment,the gastric juice pH and hemoglobin level in both groups increased,and those in the group A were higher than the group B(P<0.05).The hemostasis time in the group A was shorter than that in the group B(P<0.05).The total effective rate of treatment in the group A was higher than that in the group B(P<0.05).Conclusion High-dose octreotide combined with lansoprazole in the treatment of cirrhosis with upper gastrointestinal bleeding is more conducive to ameliorate the gastric juice pH and hemoglobin level,shorten the hemostasis time and improve the treatment effect of patients.
作者 许晓虹 李军辉 史智英 XU Xiao-hong;LI Jun-hui;SHI Zhi-ying(Yangling Demonstration Zone Hospital,Yangling 712100,China)
机构地区 杨凌示范区医院
出处 《临床医学研究与实践》 2020年第1期72-73,共2页 Clinical Research and Practice
关键词 肝硬化 上消化道出血 奥曲肽 兰索拉唑 奥美拉唑 cirrhosis upper gastrointestinal bleeding octreotide lansoprazole omeprazole
  • 相关文献

二级参考文献87

  • 1方呈祥,孙海燕.生长抑素对老年恶性肠梗阻患者的疗效[J].中国老年学杂志,2014,34(7):1965-1966. 被引量:16
  • 2陆星华,张泰昌.食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年)[J].中华消化内镜杂志,2004,21(3):149-151. 被引量:430
  • 3Groszmann RJ, Wongcharatrawee S. The hepatic venous pres- sure gradient: Anything worth doing should be done right [J]. Hepatology, 2004, 39(2):280-283.
  • 4de Franchis R. Evolving consensus in portal hypertension. Rev port of the Baveno IV consensus workshop on methology of diag- nosis and therapy in portal hypertension[J]. J Hepatol, 2005, 43 (1): 167-176.
  • 5Ge PS, Runyon BA. The changing role of beta-blocker therapy in patients with cirrhosis[J]. J Hepatol 2014,60(3):643-653.
  • 6Vlachogiannakos J, Kougioumtzian A, Triantos C, et al. The ef- fect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhosis with bleeding varices [J]. Aliment Pharmacol Ther, 2007, 26(11-12): 1479-1487.
  • 7Guadalupe GT, Arun JS, Norman DG, et al. Prevention and man- agement of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J]. Hepatology, 2007, 46(3): 922-938.
  • 8Guadalupe GT, Joseph L, and Members of the Veterans Affairs Hepatitis C Resource Center Program. Management and treat- ment of patients with cirrhosis and portal hypertension: recom- mendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program [ J ]. Am J Gastroenterol, 2009, 10g (7): 1802-1829.
  • 9Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic para- digm for patients with cirrhosis [J]. Hepatology, 2012, 56(5): 1883-1992.
  • 10Simonetto DA, Shah VH, Kamath PS. Primary prophylaxis of variceal bleeding [J ]. Clin Liver Dis ,2014,18(2):335-345.

共引文献331

同被引文献82

引证文献11

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部